Related references
Note: Only part of the references are listed.The Effect of Methylphenidate on Prefrontal Cognitive Functioning, Inattention, and Hyperactivity in Velocardiofacial Syndrome
Tamar Green et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2011)
S-Adenosyl Methionine (SAMe) Augmentation of Serotonin Reuptake Inhibitors for Antidepressant Nonresponders With Major Depressive Disorder: A Double-Blind, Randomized Clinical Trial
George I. Papakostas et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Improvement of aggressive behavior and quality of life impairment following S-Adenosyl-Methionine (SAM-e) augmentation in schizophrenia
Rael D. Strous et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2009)
A direct comparison of effect sizes from the clinical global impression-improvement scale to effect sizes from other rating scales in controlled trials of adult social anxiety disorder
Dawson W. Hedges et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2009)
Evidence for S-Adenosyl-L-Methionine (SAM-e) for the Treatment of Major Depressive Disorder
George I. Papakostas
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Psychiatric Disorders and Intellectual Functioning Throughout Development in Velocardiofacial (22q11.2 Deletion) Syndrome
Tamar Green et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2009)
Plasma and brain concentrations of oral therapeutic doses of methylphenidate and their impact on brain monoamine content in mice
Aygul Balcioglu et al.
NEUROPHARMACOLOGY (2009)
Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome
Doron Gothelf et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Manic symptoms and behavioral dysregulation in youth with velocardiofacial syndrome (22q11.2 deletion syndrome)
Alka Aneja et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2007)
COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome
D Gothelf et al.
NATURE NEUROSCIENCE (2005)
S-adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder -: An open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxine
JE Alpert et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2004)
Genetic and neurochemical modulation of prefrontal cognitive functions in children
A Diamond et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Bioavailability and lack of toxicity of S-adenosyl-L-methionine (SAMe) in humans
JL Gören et al.
PHARMACOTHERAPY (2004)
Cognitive deficits associated with schizophrenia in velo-cardio-facial syndrome
T van Amelsvoort et al.
SCHIZOPHRENIA RESEARCH (2004)
A population-based study of the 22q11.2 deletion: Phenotype, incidence, and contribution to major birth defects in the population
LD Botto et al.
PEDIATRICS (2003)
Psychiatric disorders and behavioral problems in children with velocardiofacial syndrome: Usefulness as phenotypic indicators of schizophrenia risk
C Feinstein et al.
BIOLOGICAL PSYCHIATRY (2002)
COMT-dependent protection of dopaminergic neurons by methionine, dimethionine and S-adenosylmethionine (SAM) against L-dopa toxicity in vitro
P Werner et al.
BRAIN RESEARCH (2001)
Farnesyl-L-cysteine analogs block SAM-induced Parkinson's disease-like symptoms in rats
NS Lamango et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2000)